GEN - Genesis Healthcare, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
255.45M
Enterprise Value 3
4.24B
Trailing P/E
N/A
Forward P/E 1
-3.97
PEG Ratio (5 yr expected) 1
-0.33
Price/Sales (ttm)
0.06
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
0.92
Enterprise Value/EBITDA 6
17.84

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 312.95%
S&P500 52-Week Change 315.97%
52 Week High 31.7400
52 Week Low 30.9200
50-Day Moving Average 31.3737
200-Day Moving Average 31.2347

Share Statistics

Avg Vol (3 month) 3236.86k
Avg Vol (10 day) 3273.88k
Shares Outstanding 5107.73M
Float 69.62M
% Held by Insiders 17.46%
% Held by Institutions 10.68%
Shares Short (Oct 31, 2019) 44.15M
Short Ratio (Oct 31, 2019) 417.78
Short % of Float (Oct 31, 2019) 45.52%
Short % of Shares Outstanding (Oct 31, 2019) 42.52%
Shares Short (prior month Sep 30, 2019) 44.27M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 211/10
Last Split Date 3Apr 4, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -0.93%
Operating Margin (ttm)1.66%

Management Effectiveness

Return on Assets (ttm)1.06%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.62B
Revenue Per Share (ttm)43.72
Quarterly Revenue Growth (yoy)-7.70%
Gross Profit (ttm)2.19B
EBITDA 237.62M
Net Income Avi to Common (ttm)-42.94M
Diluted EPS (ttm)-0.4070
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.84M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)4.42B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.76
Book Value Per Share (mrq)-6.92

Cash Flow Statement

Operating Cash Flow (ttm)20.28M
Levered Free Cash Flow (ttm)-425.26M